A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
Phase 3
Completed
- Conditions
- COPD
- Registration Number
- NCT00215436
- Lead Sponsor
- Dey
- Brief Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 345
Inclusion Criteria
- Medical diagnosis of COPD
- Current or prior history of cigarette smoking
Exclusion Criteria
- Medical diagnosis of asthma
- Chest X-ray diagnostic of significant disease other than COPD
- Significant condition or disease other than COPD
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Measure of lung function
- Secondary Outcome Measures
Name Time Method Change in lung function, as well as vital signs Physical Exam results, Adverse event reporting, etc
Trial Locations
- Locations (1)
Research Site
🇺🇸Milwaukee, Wisconsin, United States